DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pegsunercept
Pegsunercept
A New Venue of TNF Targeting
Pdf(4)
Diabetes Reduces Mesenchymal Stem Cells in Fracture Healing Through a Tnfα-Mediated Mechanism
Modifications to the Harmonized Tariff Schedule of the United States To
Immunfarmakológia Immunfarmakológia
Review Doi:10.1093/Rheumatology/Ket278 Pegylated Drugs in Rheumatology—Why Develop Them and Do They Work?
The Journal of Rheumatology Volume 74, No. Soluble TNF Receptors In
Synovial Tissue Rank Ligand Expression and Radiographic
15. COVID-19 Tedavisinde IL-1, IL-6 Ve TNF-Α Anti-Sitokin Monoklonal Antikor Kullanımı Prof
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Golimumab: a New Anti-TNF Agent on the Horizon for Inflammatory Arthritis
Novel Strategies for Immune Therapy of Arthritis
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
INTRODUCTION Cardiovascular Risk Reduction in Rheumatic Diseases: How Can It Be Achieved?
TNF-A Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1
A New Venue of TNF Targeting
Top View
Development of (Bio)Pharmaceuticals: Structure and Formulation Considerations
Who Expert Committee on Specifications for Pharmaceutical Preparations
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Who Drug Information
(12) Patent Application Publication (10) Pub. No.: US 2015/0064193 A1 Wang (43) Pub
2U11/111U34 a L
WO 2017/125402 Al 27 July 2017 (27.07.2017) P O P C T
Customs Tariff - Schedule Xxi - 1
Macromolecule Tumor Necrosis Factor Inhibitors: Are More Better?
Tnfα Contributes to Diabetes Impaired Angiogenesis in Fracture Healing Jason C
Download Dit Nummer (PDF)
PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
Mai Muuttunutul Mitt | Mimiti Di
International Nonproprietary Names for Pharmaceutical Substances (INN)
Treatment of Inflammatory Immunologic Disease 3. Anti-TNF Therapy in Rheumatoid Arthritis
Interactions of Viral and Cellular Tumour Necrosis Factor Receptor
Patent Owner Response
Uva-DARE (Digital Academic Repository)
(12) United States Patent (10) Patent No.: US 9,636,332 B2 Zarnitsyn Et Al
(12) Patent Application Publication (10) Pub. No.: US 2011/0158978 A1 Kirchner Et Al
Merck & Co., Inc. Policy on Posting of Redacted Study Protocols on Journal
Patent Application Publication ( 10 ) Pub . No . : US 2018 / 0325884 A1
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Hamid Reza Ravanbod Thesis
Hitta Ett Inn Nohtunut Muut
Impaired Wound Healing in Mouse Models of Diabetes Is Mediated by TNF-Α Dysregulation and Associated with Enhanced Activation of Forkhead Box O1 (FOXO1)
Pegylated Drugs in Rheumatology—Why Develop Them and Do They Work?
WO 2017/177179 Al 12 October 2017 (12.10.2017) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Chemokine Expression Is Upregulated in Chondrocytes in Diabetic Fracture Healing
Dexamethasone to Reduce Stem Cell Accumulation in the Spleen
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri